NCT00778791View on ClinicalTrials.gov

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2004

Study Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

metformin HC1 750 mg extended-release tablets

Trial Locations (1)

63301

Gateway medical research, Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778791 - Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions | Biotech Hunter | Biotech Hunter